M

Mabylon AG

19 employees

Biotech from the University of Zurich developing human antibodies to treat neurological diseases and severe allergies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2015

FAQ